Helicobacter pylori and neurological diseases: Married by the laws of inflammation
- PMID: 25400983
- PMCID: PMC4231504
- DOI: 10.4291/wjgp.v5.i4.400
Helicobacter pylori and neurological diseases: Married by the laws of inflammation
Abstract
The purpose of this paper is to review current information about the role of inflammation caused by Helicobacter pylori (H. pylori) infection in neurological diseases such as Parkinson's disease, Alzheimer's disease, Guillain-Barré syndrome, multiple sclerosis, and other inflammatory diseases including ischemic stroke. Infection with H. pylori usually persists throughout life, resulting in a chronic inflammatory response with local secretion of numerous inflammatory mediators including chemokines [interleukin (IL)-8, macrophage chemotactic protein (MCP)-1, growth-regulated oncogene (GRO)-α] and cytokines [IL-1β, tumor necrosis factor (TNF)-α, IL-6, IL-12, interferon (IFN)-γ], which can pass into the circulation and have a systemic effect. The persistence of detectable systemic and local concentrations of inflammatory mediators is likely to alter the outcome of neurological diseases. These proinflammatory factors can induce brain inflammation and the death of neurons and could eventually be associated to Parkinson's disease and also may be involved in the development of Alzheimer's disease. However, most neurological diseases are the result of a combination of multiple factors, but the systemic inflammatory response is a common component and determinant in the onset, evolution, and outcome of diseases. However, more studies are needed to allow understanding of the effects and mechanisms by which the inflammatory response generated by H. pylori infection affects neurological diseases.
Keywords: Gastrointestinal diseases; Helicobacter pylori; Immune disease; Mediators of inflammation; Neurodegenerative diseases.
Figures
Similar articles
-
Research progress on Helicobacter pylori infection related neurological diseases.Ageing Res Rev. 2024 Aug;99:102399. doi: 10.1016/j.arr.2024.102399. Epub 2024 Jun 30. Ageing Res Rev. 2024. PMID: 38955263 Review.
-
CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.Clin Exp Immunol. 2000 Nov;122(2):192-9. doi: 10.1046/j.1365-2249.2000.01374.x. Clin Exp Immunol. 2000. PMID: 11091274 Free PMC article.
-
Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.BMC Cancer. 2017 May 30;17(1):384. doi: 10.1186/s12885-017-3310-9. BMC Cancer. 2017. PMID: 28558708 Free PMC article.
-
The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection.Microb Pathog. 2015 Apr;81:33-8. doi: 10.1016/j.micpath.2015.03.010. Epub 2015 Mar 13. Microb Pathog. 2015. PMID: 25773771 Review.
-
Chemokines in the gastric mucosa in Helicobacter pylori infection.Gut. 1998 May;42(5):609-17. doi: 10.1136/gut.42.5.609. Gut. 1998. PMID: 9659152 Free PMC article.
Cited by
-
Influence of gut microbiota on eye diseases: an overview.Ann Med. 2021 Dec;53(1):750-761. doi: 10.1080/07853890.2021.1925150. Ann Med. 2021. PMID: 34042554 Free PMC article. Review.
-
Gastrointestinal disorders associated with migraine: A comprehensive review.World J Gastroenterol. 2016 Sep 28;22(36):8149-60. doi: 10.3748/wjg.v22.i36.8149. World J Gastroenterol. 2016. PMID: 27688656 Free PMC article. Review.
-
The gastrointestinal tract and Parkinson's disease.Front Cell Infect Microbiol. 2024 Jan 15;13:1158986. doi: 10.3389/fcimb.2023.1158986. eCollection 2023. Front Cell Infect Microbiol. 2024. PMID: 38292855 Free PMC article. Review. No abstract available.
-
Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.Dig Dis Sci. 2018 Apr;63(4):870-880. doi: 10.1007/s10620-018-4914-x. Epub 2018 Jan 22. Dig Dis Sci. 2018. PMID: 29357083 Free PMC article.
-
Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancer.Infect Agent Cancer. 2017 Apr 27;12:22. doi: 10.1186/s13027-017-0133-x. eCollection 2017. Infect Agent Cancer. 2017. PMID: 28465717 Free PMC article.
References
-
- Montecucco C, Rappuoli R. Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol. 2001;2:457–466. - PubMed
-
- Hamajima N, Goto Y, Nishio K, Tanaka D, Kawai S, Sakakibara H, Kondo T. Helicobacter pylori eradication as a preventive tool against gastric cancer. Asian Pac J Cancer Prev. 2004;5:246–252. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous